Akcea Therapeutics, INC.
SEC CIK 1662524 · AKCA · last insider filing 2020-10-14
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Parshall B Lynne | Director | filed 2017 - 2020 |
| Klein Joseph III | Director | filed 2019 - 2020 |
| Smith Sandford D | Director | filed 2017 - 2020 |
| Yanni Barbara | Director | filed 2019 - 2020 |
| Salzman Amber | Director | filed 2020 - 2020 |
| Yang Michael J. | Director | filed 2019 - 2020 |
| Hochberg Elaine | Director | filed 2017 - 2020 |
| Mcdevitt Damien | Director · Interim Chief Executive Office | filed 2018 - 2020 |
| Soteropoulos Paula | Director · President & CEO | filed 2017 - 2019 |
| Boyce Sarah | Director · President | filed 2018 - 2019 |
| Moscicki Richard A | Director | filed 2018 - 2019 |
| Gabrieli Christopher | Director | filed 2017 - 2019 |
| Fitzgerald Edward M | Director | filed 2017 - 2019 |
| Crooke Stanley T | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Price Michael Dennis | Chief Financial Officer | filed 2020 - 2020 |
| Andrews William T. | Chief Medical Officer | filed 2020 - 2020 |
| Jenne Kyle | Chief Commercial Officer | filed 2019 - 2020 |
| Howarth Alex G. | Chief Operating Officer | filed 2019 - 2020 |
| Patterson Joshua F. | General Counsel | filed 2020 - 2020 |
| O'Dea Louis | Chief Medical Officer | filed 2017 - 2020 |
| Maclean Michael F | Chief Financial Officer | filed 2017 - 2020 |
| Goldberg Jeff Marc | Chief Operating Officer | filed 2017 - 2019 |
| Hougen Elizabeth L | Chief Financial Officer | filed 2017 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.